期刊文献+

盐酸法舒地尔在治疗冠心病心力衰竭中的临床疗效 被引量:4

下载PDF
导出
摘要 目的:分析研究盐酸法舒地尔对冠心病心力衰竭患者的临床疗效和安全性。方法:将94例冠心病心力衰竭患者随机分为观察组和对照组各47例,对照组给予内科常规治疗,观察组在内科常规治疗基础上加用盐酸法舒地尔。两组分别在用药前和用药2周时行多普勒超声心动图检查和6MWD试验,观察LVEDD、LVESD及LVEF,并评价心脏收缩功能和运动能力的改善情况。结果:观察组治疗总有效率89.36%,对照组治疗总有效率72.34%,观察组高于对照组,两组比较差异有统计学意义(P<0.05)。疗程结束时两组行多普勒超声心动图和6MWD试验,各项指标较治疗前均有所改善。观察组LVEDD、LVESD、LVEF及6MWD改善情况与对照组比较,差异有统计学意义(P<0.05)。结论:在常规内科治疗基础上,应用盐酸法舒地尔能显著改善冠心病心力衰竭患者的心功能,改善心室重构,增加患者运动耐力。
作者 姬洪涛
出处 《中国社区医师(医学专业)》 2011年第30期77-77,共1页
  • 相关文献

参考文献7

二级参考文献34

  • 1张曼,屈晨,曾定尹.Rho/Rho激酶在压力负荷心力衰竭大鼠心肌组织的表达[J].中华心血管病杂志,2005,33(1):73-76. 被引量:52
  • 2陈协兴,洪华山.6分钟步行试验在慢性心力衰竭中的应用[J].世界临床药物,2005,26(4):212-215. 被引量:18
  • 3李福伟,徐家华,吴玄光,孙俊颖,张桂红.心力衰竭的病理生理研究进展[J].动物医学进展,2005,26(9):17-21. 被引量:6
  • 4罗洁,闵苏.新型脑、心血管活性药——法舒地尔[J].中国新药与临床杂志,2006,25(12):941-945. 被引量:47
  • 5Leung T, Manser E, Tan L, el al. A novel serine/threonine kinase binding the Ras - related RhoA GTPase which translocates the kinase to periphersl membranes[ J ]. J Biol Chem, 1995, 270 (49) : 29 051- 29 054.
  • 6Funakoshi Y, Ichiki T, Shiookawa H, et al. Rho - kinase mediates angiotensionII- induced monocyte chemottractant protein - 1 expression in rat vascular smooth muscle cells [ J ]. Hypertension, 2001, 38(10):100- 104.
  • 7Takeda K, Lchiki T, Tokunou T, et al. Critical role of Rho - kinase and MEK/ERK pathways for angiotensin II induced plasminogen activator inhibitor type - 4 gene expression [ J ]. Arterioscler Thromb Vase Biol, 2001, 21(5):868 - 873.
  • 8Sauzeau V, MeUbnnec E, Bertoglio J, et al. Human urotensin II - induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho - kinase[J]. Circ Res, 2001, 88 (11):1 102-1 104.
  • 9Uehato M, Ishizaki T, Satoh H, el al. Calcium sensitization of smooth muscle mediated by a Rho - associated protein kinase in hypertension[J]. Nature, 1997, 389 : 990 - 994.
  • 10Wang YX, Da Cunba V, Martin - McNulty B, et al. Inhibition of Rho - kinase by fasudil attenuated angiotensin II- induced cardiac hypertrophy in apolipoprotein E deficient mice[J]. Eur J pharmacol, 2005, 512(2 - 3) :215 - 222.

共引文献2487

同被引文献34

  • 1张曼,屈晨,曾定尹.Rho/Rho激酶在压力负荷心力衰竭大鼠心肌组织的表达[J].中华心血管病杂志,2005,33(1):73-76. 被引量:52
  • 2李福伟,徐家华,吴玄光,孙俊颖,张桂红.心力衰竭的病理生理研究进展[J].动物医学进展,2005,26(9):17-21. 被引量:6
  • 3Lauriol J, Keith K, Jaffr6 cardiomyocytes protects against facilitates cardiac fibrosis [J] ral00. F, et al. RhoA signaling in stress-induced heart failure but Sci Signal, 2014,7 (348).
  • 4陈灏珠.内科学[M].4版.北京:民卫生出版社,1996:136.
  • 5Uehata M, Ishizki T, Satoh H, et al. Calcium sensitization of smooth muscle mediated by a Rho-associatcd protein kinase in hypertension [J]. Nature, 1997,389(6654) : 990-994.
  • 6Loirand G, Gu6rin P, Pacaud P. Rho kinases in cardiovascular physiology and pathophysiology [J]. Circ Res, 2006,98 (3): 322-334.
  • 7Wang YX, da Cunha V, Martin-menuhy B, et al. Inhibition of Rho-kinase by fasudil attenuated angiotensin l] cardiac hypertrophy in apolipoprotein E deficient mice [J]. Euro J Pharmacol, 2005(2-3) : 215-222.
  • 8Kwok W, Clemens MG. Rho-kinase activation contributes to Lps-induced impairment of Endothelial Nitric Oxide Synthase Activation by Endothelin-1 in cultured hepatic sinusoidal endothelial cells [J]. Shock (Augusta, Ga.), 2014,42 (6) : 554-561.
  • 9Noma K, Oyama N, Liao JK, Physiological role of ROCKS in the cardiovascular system [J]. Am J Physiol Cell Physiol, 2006, 290(5 ) :661-666.
  • 10无.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095. 被引量:3684

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部